Cargando…

A longitudinal study of patients with cirrhosis treated with L-ornithine L-aspartate, examined with magnetization transfer, diffusion-weighted imaging and magnetic resonance spectroscopy

The presence of overt hepatic encephalopathy (HE) is associated with structural, metabolic and functional changes in the brain discernible by use of a variety of magnetic resonance (MR) techniques. The changes in patients with minimal HE are less well documented. Twenty-two patients with well-compen...

Descripción completa

Detalles Bibliográficos
Autores principales: Grover, Vijay P. B., McPhail, Mark J. W., Wylezinska-Arridge, Marzena, Crossey, Mary M. E., Fitzpatrick, Julie A., Southern, Louise, Saxby, Brian K., Cook, Nicola A., Cox, I. Jane, Waldman, Adam D., Dhanjal, Novraj S., Bak-Bol, Aluel, Williams, Roger, Morgan, Marsha Y., Taylor-Robinson, Simon D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5225223/
https://www.ncbi.nlm.nih.gov/pubmed/27488112
http://dx.doi.org/10.1007/s11011-016-9881-3
_version_ 1782493477521588224
author Grover, Vijay P. B.
McPhail, Mark J. W.
Wylezinska-Arridge, Marzena
Crossey, Mary M. E.
Fitzpatrick, Julie A.
Southern, Louise
Saxby, Brian K.
Cook, Nicola A.
Cox, I. Jane
Waldman, Adam D.
Dhanjal, Novraj S.
Bak-Bol, Aluel
Williams, Roger
Morgan, Marsha Y.
Taylor-Robinson, Simon D.
author_facet Grover, Vijay P. B.
McPhail, Mark J. W.
Wylezinska-Arridge, Marzena
Crossey, Mary M. E.
Fitzpatrick, Julie A.
Southern, Louise
Saxby, Brian K.
Cook, Nicola A.
Cox, I. Jane
Waldman, Adam D.
Dhanjal, Novraj S.
Bak-Bol, Aluel
Williams, Roger
Morgan, Marsha Y.
Taylor-Robinson, Simon D.
author_sort Grover, Vijay P. B.
collection PubMed
description The presence of overt hepatic encephalopathy (HE) is associated with structural, metabolic and functional changes in the brain discernible by use of a variety of magnetic resonance (MR) techniques. The changes in patients with minimal HE are less well documented. Twenty-two patients with well-compensated cirrhosis, seven of whom had minimal HE, were examined with cerebral 3 Tesla MR techniques, including T(1)- and T(2)-weighted, magnetization transfer and diffusion-weighted imaging and proton magnetic resonance spectroscopy sequences. Studies were repeated after a 4-week course of oral L-ornithine L-aspartate (LOLA). Results were compared with data obtained from 22 aged-matched healthy controls. There was no difference in mean total brain volume between patients and controls at baseline. Mean cerebral magnetization transfer ratios were significantly reduced in the globus pallidus and thalamus in the patients with cirrhosis irrespective of neuropsychiatric status; the mean ratio was significantly reduced in the frontal white matter in patients with minimal HE compared with healthy controls but not when compared with their unimpaired counterparts. There were no significant differences in either the median apparent diffusion coefficients or the mean fractional anisotropy, calculated from the diffusion-weighted imaging, or in the mean basal ganglia metabolite ratios between patients and controls. Psychometric performance improved in 50 % of patients with minimal HE following LOLA, but no significant changes were observed in brain volumes, cerebral magnetization transfer ratios, the diffusion weighted imaging variables or the cerebral metabolite ratios. MR variables, as applied in this study, do not identify patients with minimal HE, nor do they reflect changes in psychometric performance following LOLA. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s11011-016-9881-3) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5225223
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-52252232017-01-24 A longitudinal study of patients with cirrhosis treated with L-ornithine L-aspartate, examined with magnetization transfer, diffusion-weighted imaging and magnetic resonance spectroscopy Grover, Vijay P. B. McPhail, Mark J. W. Wylezinska-Arridge, Marzena Crossey, Mary M. E. Fitzpatrick, Julie A. Southern, Louise Saxby, Brian K. Cook, Nicola A. Cox, I. Jane Waldman, Adam D. Dhanjal, Novraj S. Bak-Bol, Aluel Williams, Roger Morgan, Marsha Y. Taylor-Robinson, Simon D. Metab Brain Dis Original Article The presence of overt hepatic encephalopathy (HE) is associated with structural, metabolic and functional changes in the brain discernible by use of a variety of magnetic resonance (MR) techniques. The changes in patients with minimal HE are less well documented. Twenty-two patients with well-compensated cirrhosis, seven of whom had minimal HE, were examined with cerebral 3 Tesla MR techniques, including T(1)- and T(2)-weighted, magnetization transfer and diffusion-weighted imaging and proton magnetic resonance spectroscopy sequences. Studies were repeated after a 4-week course of oral L-ornithine L-aspartate (LOLA). Results were compared with data obtained from 22 aged-matched healthy controls. There was no difference in mean total brain volume between patients and controls at baseline. Mean cerebral magnetization transfer ratios were significantly reduced in the globus pallidus and thalamus in the patients with cirrhosis irrespective of neuropsychiatric status; the mean ratio was significantly reduced in the frontal white matter in patients with minimal HE compared with healthy controls but not when compared with their unimpaired counterparts. There were no significant differences in either the median apparent diffusion coefficients or the mean fractional anisotropy, calculated from the diffusion-weighted imaging, or in the mean basal ganglia metabolite ratios between patients and controls. Psychometric performance improved in 50 % of patients with minimal HE following LOLA, but no significant changes were observed in brain volumes, cerebral magnetization transfer ratios, the diffusion weighted imaging variables or the cerebral metabolite ratios. MR variables, as applied in this study, do not identify patients with minimal HE, nor do they reflect changes in psychometric performance following LOLA. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s11011-016-9881-3) contains supplementary material, which is available to authorized users. Springer US 2016-08-03 2017 /pmc/articles/PMC5225223/ /pubmed/27488112 http://dx.doi.org/10.1007/s11011-016-9881-3 Text en © The Author(s) 2016 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Original Article
Grover, Vijay P. B.
McPhail, Mark J. W.
Wylezinska-Arridge, Marzena
Crossey, Mary M. E.
Fitzpatrick, Julie A.
Southern, Louise
Saxby, Brian K.
Cook, Nicola A.
Cox, I. Jane
Waldman, Adam D.
Dhanjal, Novraj S.
Bak-Bol, Aluel
Williams, Roger
Morgan, Marsha Y.
Taylor-Robinson, Simon D.
A longitudinal study of patients with cirrhosis treated with L-ornithine L-aspartate, examined with magnetization transfer, diffusion-weighted imaging and magnetic resonance spectroscopy
title A longitudinal study of patients with cirrhosis treated with L-ornithine L-aspartate, examined with magnetization transfer, diffusion-weighted imaging and magnetic resonance spectroscopy
title_full A longitudinal study of patients with cirrhosis treated with L-ornithine L-aspartate, examined with magnetization transfer, diffusion-weighted imaging and magnetic resonance spectroscopy
title_fullStr A longitudinal study of patients with cirrhosis treated with L-ornithine L-aspartate, examined with magnetization transfer, diffusion-weighted imaging and magnetic resonance spectroscopy
title_full_unstemmed A longitudinal study of patients with cirrhosis treated with L-ornithine L-aspartate, examined with magnetization transfer, diffusion-weighted imaging and magnetic resonance spectroscopy
title_short A longitudinal study of patients with cirrhosis treated with L-ornithine L-aspartate, examined with magnetization transfer, diffusion-weighted imaging and magnetic resonance spectroscopy
title_sort longitudinal study of patients with cirrhosis treated with l-ornithine l-aspartate, examined with magnetization transfer, diffusion-weighted imaging and magnetic resonance spectroscopy
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5225223/
https://www.ncbi.nlm.nih.gov/pubmed/27488112
http://dx.doi.org/10.1007/s11011-016-9881-3
work_keys_str_mv AT grovervijaypb alongitudinalstudyofpatientswithcirrhosistreatedwithlornithinelaspartateexaminedwithmagnetizationtransferdiffusionweightedimagingandmagneticresonancespectroscopy
AT mcphailmarkjw alongitudinalstudyofpatientswithcirrhosistreatedwithlornithinelaspartateexaminedwithmagnetizationtransferdiffusionweightedimagingandmagneticresonancespectroscopy
AT wylezinskaarridgemarzena alongitudinalstudyofpatientswithcirrhosistreatedwithlornithinelaspartateexaminedwithmagnetizationtransferdiffusionweightedimagingandmagneticresonancespectroscopy
AT crosseymaryme alongitudinalstudyofpatientswithcirrhosistreatedwithlornithinelaspartateexaminedwithmagnetizationtransferdiffusionweightedimagingandmagneticresonancespectroscopy
AT fitzpatrickjuliea alongitudinalstudyofpatientswithcirrhosistreatedwithlornithinelaspartateexaminedwithmagnetizationtransferdiffusionweightedimagingandmagneticresonancespectroscopy
AT southernlouise alongitudinalstudyofpatientswithcirrhosistreatedwithlornithinelaspartateexaminedwithmagnetizationtransferdiffusionweightedimagingandmagneticresonancespectroscopy
AT saxbybriank alongitudinalstudyofpatientswithcirrhosistreatedwithlornithinelaspartateexaminedwithmagnetizationtransferdiffusionweightedimagingandmagneticresonancespectroscopy
AT cooknicolaa alongitudinalstudyofpatientswithcirrhosistreatedwithlornithinelaspartateexaminedwithmagnetizationtransferdiffusionweightedimagingandmagneticresonancespectroscopy
AT coxijane alongitudinalstudyofpatientswithcirrhosistreatedwithlornithinelaspartateexaminedwithmagnetizationtransferdiffusionweightedimagingandmagneticresonancespectroscopy
AT waldmanadamd alongitudinalstudyofpatientswithcirrhosistreatedwithlornithinelaspartateexaminedwithmagnetizationtransferdiffusionweightedimagingandmagneticresonancespectroscopy
AT dhanjalnovrajs alongitudinalstudyofpatientswithcirrhosistreatedwithlornithinelaspartateexaminedwithmagnetizationtransferdiffusionweightedimagingandmagneticresonancespectroscopy
AT bakbolaluel alongitudinalstudyofpatientswithcirrhosistreatedwithlornithinelaspartateexaminedwithmagnetizationtransferdiffusionweightedimagingandmagneticresonancespectroscopy
AT williamsroger alongitudinalstudyofpatientswithcirrhosistreatedwithlornithinelaspartateexaminedwithmagnetizationtransferdiffusionweightedimagingandmagneticresonancespectroscopy
AT morganmarshay alongitudinalstudyofpatientswithcirrhosistreatedwithlornithinelaspartateexaminedwithmagnetizationtransferdiffusionweightedimagingandmagneticresonancespectroscopy
AT taylorrobinsonsimond alongitudinalstudyofpatientswithcirrhosistreatedwithlornithinelaspartateexaminedwithmagnetizationtransferdiffusionweightedimagingandmagneticresonancespectroscopy
AT grovervijaypb longitudinalstudyofpatientswithcirrhosistreatedwithlornithinelaspartateexaminedwithmagnetizationtransferdiffusionweightedimagingandmagneticresonancespectroscopy
AT mcphailmarkjw longitudinalstudyofpatientswithcirrhosistreatedwithlornithinelaspartateexaminedwithmagnetizationtransferdiffusionweightedimagingandmagneticresonancespectroscopy
AT wylezinskaarridgemarzena longitudinalstudyofpatientswithcirrhosistreatedwithlornithinelaspartateexaminedwithmagnetizationtransferdiffusionweightedimagingandmagneticresonancespectroscopy
AT crosseymaryme longitudinalstudyofpatientswithcirrhosistreatedwithlornithinelaspartateexaminedwithmagnetizationtransferdiffusionweightedimagingandmagneticresonancespectroscopy
AT fitzpatrickjuliea longitudinalstudyofpatientswithcirrhosistreatedwithlornithinelaspartateexaminedwithmagnetizationtransferdiffusionweightedimagingandmagneticresonancespectroscopy
AT southernlouise longitudinalstudyofpatientswithcirrhosistreatedwithlornithinelaspartateexaminedwithmagnetizationtransferdiffusionweightedimagingandmagneticresonancespectroscopy
AT saxbybriank longitudinalstudyofpatientswithcirrhosistreatedwithlornithinelaspartateexaminedwithmagnetizationtransferdiffusionweightedimagingandmagneticresonancespectroscopy
AT cooknicolaa longitudinalstudyofpatientswithcirrhosistreatedwithlornithinelaspartateexaminedwithmagnetizationtransferdiffusionweightedimagingandmagneticresonancespectroscopy
AT coxijane longitudinalstudyofpatientswithcirrhosistreatedwithlornithinelaspartateexaminedwithmagnetizationtransferdiffusionweightedimagingandmagneticresonancespectroscopy
AT waldmanadamd longitudinalstudyofpatientswithcirrhosistreatedwithlornithinelaspartateexaminedwithmagnetizationtransferdiffusionweightedimagingandmagneticresonancespectroscopy
AT dhanjalnovrajs longitudinalstudyofpatientswithcirrhosistreatedwithlornithinelaspartateexaminedwithmagnetizationtransferdiffusionweightedimagingandmagneticresonancespectroscopy
AT bakbolaluel longitudinalstudyofpatientswithcirrhosistreatedwithlornithinelaspartateexaminedwithmagnetizationtransferdiffusionweightedimagingandmagneticresonancespectroscopy
AT williamsroger longitudinalstudyofpatientswithcirrhosistreatedwithlornithinelaspartateexaminedwithmagnetizationtransferdiffusionweightedimagingandmagneticresonancespectroscopy
AT morganmarshay longitudinalstudyofpatientswithcirrhosistreatedwithlornithinelaspartateexaminedwithmagnetizationtransferdiffusionweightedimagingandmagneticresonancespectroscopy
AT taylorrobinsonsimond longitudinalstudyofpatientswithcirrhosistreatedwithlornithinelaspartateexaminedwithmagnetizationtransferdiffusionweightedimagingandmagneticresonancespectroscopy